Log in
Enquire now

List of Cipla patents

List of Cipla patents
List of Terex patents
List of CalAmp (car company) patents
List of Level Home patents
List of companies in Valiant Capital Partners's investment portfolio
List of companies in T-Venture's investment portfolio
Patents where
Current Assignee
Name
is
CiplaCipla
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10940274 Nasal spray assembly

Patent 10940274 was granted and assigned to Cipla on March, 2021 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
10940274
March 9, 2021
‌
US Patent 8006695 Inhaler

Patent 8006695 was granted and assigned to Cipla on August, 2011 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
8006695
August 30, 2011
‌
US Patent 7638627 Process of preparing imatinib and imatinib prepared thereby

Patent 7638627 was granted and assigned to Cipla on December, 2009 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
7638627
December 29, 2009
‌
US Patent 11464425 Flow sensing arrangement for spirometer and method thereof

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
11464425
October 11, 2022
‌
US Patent 7395821 Multi-dose inhaler

Patent 7395821 was granted and assigned to Cipla on July, 2008 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
7395821
July 8, 2008
‌
US Patent 10966982 Stable pharmaceutical formulations of pemetrexed

Patent 10966982 was granted and assigned to Cipla on April, 2021 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
10966982
April 6, 2021
‌
US Patent 7404400 Spacer device for inhaler

Patent 7404400 was granted and assigned to Cipla on July, 2008 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
7404400
July 29, 2008
‌
US Patent 7550593 Process for the preparation of finasteride Form I

Patent 7550593 was granted and assigned to Cipla on June, 2009 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
7550593
June 23, 2009
‌
US Patent 9901585 Combination of azelastine and fluticasone for nasal administration

Patent 9901585 was granted and assigned to Cipla on February, 2018 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
9901585
February 27, 2018
‌
US Patent 11478483 Method of treating hypertension

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
11478483
October 25, 2022
‌
US Patent 8168620 Combination of azelastine and steroids

Patent 8168620 was granted and assigned to Cipla on May, 2012 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
8168620
May 1, 2012
‌
US Patent 8962601 Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids

Patent 8962601 was granted and assigned to Cipla on February, 2015 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
8962601
February 24, 2015
‌
US Patent 10420727 Pharmaceutical antiretroviral composition

Patent 10420727 was granted and assigned to Cipla on September, 2019 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
10420727
September 24, 2019
‌
US Patent 9993560 Rifaximin complexes

Patent 9993560 was granted and assigned to Cipla on June, 2018 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
9993560
June 12, 2018
‌
US Patent 10328153 Rifaximin complexes

Patent 10328153 was granted and assigned to Cipla on June, 2019 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
10328153
June 25, 2019
‌
US Patent 10301282 Polymorphic form X of nilotinib dihydrochloride hydrate

Patent 10301282 was granted and assigned to Cipla on May, 2019 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
10301282
May 28, 2019
‌
US Patent 8163723 Combination of azelastine and steroids

Patent 8163723 was granted and assigned to Cipla on April, 2012 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
8163723
April 24, 2012
‌
US Patent 11596597 Depot formulation

Patent 11596597 was granted and assigned to Cipla on March, 2023 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
11596597
March 7, 2023
‌
US Patent 9993561 Rifaximin complexes

Patent 9993561 was granted and assigned to Cipla on June, 2018 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
9993561
June 12, 2018
‌
US Patent 7517519 Topical immunotherapy and compositions for use therein

Patent 7517519 was granted and assigned to Cipla on April, 2009 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
7517519
April 14, 2009
‌
US Patent 9913853 Stabilized liquid fosaprepitant formulations

Patent 9913853 was granted and assigned to Cipla on March, 2018 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
9913853
March 13, 2018
‌
US Patent 8464914 Valve for an aerosol device

Patent 8464914 was granted and assigned to Cipla on June, 2013 by the United States Patent and Trademark Office.

Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
8464914
June 18, 2013
‌
US Patent 10287248 Process for the preparation of apremilast

Patent 10287248 was granted and assigned to Cipla on May, 2019 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
10287248
May 14, 2019
‌
US Patent 9505787 Process for preparing of bortezomib

Patent 9505787 was granted and assigned to Cipla on November, 2016 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
9505787
November 29, 2016
‌
US Patent 10933047 Stabilized cabazitaxel formulations

Patent 10933047 was granted and assigned to Cipla on March, 2021 by the United States Patent and Trademark Office.

Cipla
Cipla
Cipla
Cipla
United States Patent and Trademark Office
United States Patent and Trademark Office
10933047
March 2, 2021
...
Results per page:
149 results
0 selected
149 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us